Scientists from all over the world have been racing to understand the fundamentals of Devil Facial Tumour Disease and find a way to stop it. One of them is Yi Ning (Sabrina) Fu, a recent Honours graduate at JCSMR.

Around 180,000 Australians are affected by inflammatory bowel disease, but what triggers the inflammation remains unclear. Now, a group of young researchers is investigating the role of mutated immune proteins in the condition.

ANU spinoff company Ability Optics Pty Ltd is accelerating to revolutionise biotechnology with an aim to speed up early lead drug screening by 100-fold.

This Rare Disease Day, we’re spotlighting some of the incredible researchers at JCSMR working to better understand, diagnose, and treat rare diseases.

New research provides insight into how cells identify and discard faulty molecular machines responsible for RNA splicing.

Iron is an essential nutrient, but iron overload raises the risk of type two diabetes and pancreatitis, according to experts at ANU.